Results 261 to 270 of about 59,066 (338)

Peripheral Facial Palsy in Small Cell Lung Cancer with Mastoid Metastasis. [PDF]

Eur J Case Rep Intern Med
Gaspar M, Marques Silva M, Agostinho Pereira M, Silva J, Duarte N.   +4 more
europepmc   +1 more source

Surgical Approaches to Pre‐Auricular Cutaneous Squamous Cell Carcinomas Extending to the Temporal Bone

Head &Neck, Volume 47, Issue 6, Page 1736-1748, June 2025.
ABSTRACT Background Standardized surgical approaches to advanced pre‐auricular cutaneous squamous cell carcinomas (cSCC) are lacking. Methods Fifty–four patients who underwent lateral temporal bone resection (LTBR) for pre‐auricular cSCC were grouped into “Levels” of increasing disease spread.
Michael Schachtel, Mitesh Gandhi, James Bowman, Mark Midwinter, Benedict Panizza   +4 more
wiley   +1 more source

A 15-year follow-up of permanent intraoperative internal carotid artery occlusion for hemostasis in a giant cavernous sinus hemangioma: a case report. [PDF]

J Med Case Rep
Chavoshi-Nejad M, Molahoseini R, Baradaran Bagheri A, Aghajanian S.   +3 more
europepmc   +1 more source

A Pilot Trial of Tongue Reconstruction Using the Chimeric Innervated Vastus Lateralis Muscle and Antero‐Lateral Thigh Free Flap

Head &Neck, Volume 47, Issue 6, Page 1758-1768, June 2025.
ABSTRACT Background Subtotal and total glossectomies for advanced tongue cancer result in significant speech‐ and swallow‐related morbidity, impairing quality of life. This prospective pilot study compares the safety and functional outcomes associated with using a chimeric innervated muscle and fasciocutaneous flap for soft tissue reconstruction ...
Emma Charters, Jessica Boehm, Anita Macdonald D'Silva, Raymond Wu, Simon A. Mueller, Tsu‐Hui (Hubert) Low, Jonathan R. Clark, James Wykes   +7 more
wiley   +1 more source

Surgical management of cerebellopontine angle teratomas with total and subtotal approach in adults: A case report. [PDF]

Int J Surg Case Rep
Nakhutsrishvili S, Gakhokia O, Basilashvili A, Metreveli M, Alphaidze E, Shalibashvili R.   +5 more
europepmc   +1 more source

Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET

The Prostate, Volume 85, Issue 8, Page 777-783, June 2025.
ABSTRACT Background PSMA PET/CT has previously shown superior performance in nodal staging of prostate cancer (PCa) and may be used to reduce the number of unnecessary PLND procedures. This study aims to assess the performance of PSMA PET/CT in nodal staging of intermediate‐risk prostate cancer and to evaluate the effect of PLND on oncological outcomes
Baris Esen, Hulya Seymen, Ayşe Armutlu, Ersin Koseoglu, Ibrahim Can Aykanat, Hatice Zoroğlu, Abdullah Erdem Canda, Yakup Kordan, Mevlana Derya Balbay, Dilek Ertoy Baydar, Mehmet Onur Demirkol, Derya Tilki, Tarık Esen   +12 more
wiley   +1 more source

Microvascular Decompression for Trigeminal Neuralgia Using Autologous Muscle Grafting: A Retrospective Analysis in a Resource-Limited Setting. [PDF]

Cureus
Alasta A, Al Naggar AM, Al-Saidy A, Al Wesabi F.   +3 more
europepmc   +1 more source

Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review

The Prostate, Volume 85, Issue 9, Page 841-849, June 15, 2025.
ABSTRACT Background Brain metastases (BMETS) from prostate cancer are rare. Hence, brain imaging in neurologically asymptomatic patients with advanced prostate cancer (aPC) is not routinely performed. Prostate‐specific membrane antigen (PSMA) PET/CT uses a radiotracer that binds to prostate cancer epithelial cells and is FDA‐approved for initial ...
Mark Willy L. Mondia, Prem P. Batchala, Robert Dreicer, Michael E. Devitt, Matthew R. McCord, Melike Mut, Jason P. Sheehan, David Schiff, Camilo E. Fadul   +8 more
wiley   +1 more source

Cervical Vagal Schwannoma: A Case Report and Literature Review. [PDF]

Clin Case Rep
Thatal S, Karki S, Parajuli A, Agrawal Y, Paudel D.   +4 more
europepmc   +1 more source

First‐Line Immune‐Combination Therapy for Driver Gene‐Negative NSCLC With Brain Metastases: Real‐World Outcomes

Thoracic Cancer, Volume 16, Issue 11, June 2025.
The key question of this study is “what is the optimal first‐line therapy for driver gene‐negative NSCLC with brain metastases (BM), and can PD‐L1 predict intracranial efficacy?” This is a retrospective analysis of 36 patients treated with immune checkpoint inhibitor (ICI) + chemotherapy (CT) (n = 21) and ICI + CT + bevacizumab (Bev) (n = 15).
Mengxing You, Lige Wu, Jiayu Liu, Hanqi Yuan, Zihe Wang, Xuezhi Hao, Puyuan Xing, Junling Li   +7 more
wiley   +1 more source